160 related articles for article (PubMed ID: 37726712)
1. Serum tau protein elevation in migraine: a cross-sectional case-control study.
Overeem LH; Raffaelli B; Fleischmann R; Süße M; Vogelgesang A; Maceski AM; Papadopoulou A; Ruprecht K; Su W; Koch M; Siebert A; Arkuszewski M; Tenenbaum N; Kuhle J; Reuter U
J Headache Pain; 2023 Sep; 24(1):130. PubMed ID: 37726712
[TBL] [Abstract][Full Text] [Related]
2. Increased CX3CL1 in cerebrospinal fluid and ictal serum t-tau elevations in migraine: results from a cross-sectional exploratory case-control study.
Süße M; Kloetzer C; Strauß S; Ruhnau J; Overeem LH; Bendig M; Schulze J; Reuter U; Vogelgesang A; Fleischmann R
J Headache Pain; 2024 Apr; 25(1):46. PubMed ID: 38561692
[TBL] [Abstract][Full Text] [Related]
3. Serum CGRP, VIP, and PACAP usefulness in migraine: a case-control study in chronic migraine patients in real clinical practice.
Pérez-Pereda S; Toriello-Suárez M; Ocejo-Vinyals G; Guiral-Foz S; Castillo-Obeso J; Montes-Gómez S; Martínez-Nieto RM; Iglesias F; González-Quintanilla V; Oterino A
Mol Biol Rep; 2020 Sep; 47(9):7125-7138. PubMed ID: 32951099
[TBL] [Abstract][Full Text] [Related]
4. Brain-specific biomarkers in urine as a non-invasive approach to monitor neuronal and glial damage.
Kohlhase K; Frank F; Wilmes C; Koerbel K; Schaller-Paule MA; Miles M; Betz C; Steinmetz H; Foerch C
Eur J Neurol; 2023 Mar; 30(3):729-740. PubMed ID: 36409153
[TBL] [Abstract][Full Text] [Related]
5. Time course and diagnostic utility of NfL, tau, GFAP, and UCH-L1 in subacute and chronic TBI.
Shahim P; Politis A; van der Merwe A; Moore B; Ekanayake V; Lippa SM; Chou YY; Pham DL; Butman JA; Diaz-Arrastia R; Zetterberg H; Blennow K; Gill JM; Brody DL; Chan L
Neurology; 2020 Aug; 95(6):e623-e636. PubMed ID: 32641529
[TBL] [Abstract][Full Text] [Related]
6. Acute Effects of Sport-Related Concussion on Serum Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase L1, Total Tau, and Neurofilament Light Measured by a Multiplex Assay.
Asken BM; Yang Z; Xu H; Weber AG; Hayes RL; Bauer RM; DeKosky ST; Jaffee MS; Wang KKW; Clugston JR
J Neurotrauma; 2020 Jul; 37(13):1537-1545. PubMed ID: 32024456
[TBL] [Abstract][Full Text] [Related]
7. Association of Blood Biomarkers With Acute Sport-Related Concussion in Collegiate Athletes: Findings From the NCAA and Department of Defense CARE Consortium.
McCrea M; Broglio SP; McAllister TW; Gill J; Giza CC; Huber DL; Harezlak J; Cameron KL; Houston MN; McGinty G; Jackson JC; Guskiewicz K; Mihalik J; Brooks MA; Duma S; Rowson S; Nelson LD; Pasquina P; Meier TB; ; Foroud T; Katz BP; Saykin AJ; Campbell DE; Svoboda SJ; Goldman J; DiFiori J
JAMA Netw Open; 2020 Jan; 3(1):e1919771. PubMed ID: 31977061
[TBL] [Abstract][Full Text] [Related]
8. Evidence that blood-CSF barrier transport, but not inflammatory biomarkers, change in migraine, while CSF sVCAM1 associates with migraine frequency and CSF fibrinogen.
Cowan RP; Gross NB; Sweeney MD; Sagare AP; Montagne A; Arakaki X; Fonteh AN; Zlokovic BV; Pogoda JM; Harrington MG
Headache; 2021 Mar; 61(3):536-545. PubMed ID: 33724462
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of cerebrospinal fluid ubiquitin C-terminal hydrolase-L1, glial fibrillary acidic protein, and neurofilament light protein as novel markers for the diagnosis of neurosyphilis among HIV-negative patients.
Chen R; Lin LR; Xiao Y; Ke WJ; Yang TC
Int J Infect Dis; 2023 Feb; 127():36-44. PubMed ID: 36400375
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long-term outcome in patients with autoimmune encephalitis.
Constantinescu R; Krýsl D; Bergquist F; Andrén K; Malmeström C; Asztély F; Axelsson M; Menachem EB; Blennow K; Rosengren L; Zetterberg H
Eur J Neurol; 2016 Apr; 23(4):796-806. PubMed ID: 26822123
[TBL] [Abstract][Full Text] [Related]
11. Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine.
Cernuda-Morollón E; Larrosa D; Ramón C; Vega J; Martínez-Camblor P; Pascual J
Neurology; 2013 Oct; 81(14):1191-6. PubMed ID: 23975872
[TBL] [Abstract][Full Text] [Related]
12. Distinct Serum Glial Fibrillary Acidic Protein and Neurofilament Light Time-Courses After Rapid Head Rotations.
Huber CM; Thakore AD; Oeur RA; Margulies SS
J Neurotrauma; 2024 May; ():. PubMed ID: 38698671
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias.
Baiardi S; Quadalti C; Mammana A; Dellavalle S; Zenesini C; Sambati L; Pantieri R; Polischi B; Romano L; Suffritti M; Bentivenga GM; Randi V; Stanzani-Maserati M; Capellari S; Parchi P
Alzheimers Res Ther; 2022 Oct; 14(1):153. PubMed ID: 36221099
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson's disease biomarkers using multiplexed single molecule counting.
Youssef P; Hughes L; Kim WS; Halliday GM; Lewis SJG; Cooper A; Dzamko N
Sci Rep; 2023 Mar; 13(1):5217. PubMed ID: 36997567
[TBL] [Abstract][Full Text] [Related]
15. Peripheral, Interictal Serum S100B Levels are Not Increased in Chronic Migraine Patients.
Riesco N; Cernuda-Morollón E; Martínez-Camblor P; Pérez-Pereda S; Pascual J
Headache; 2020 Sep; 60(8):1705-1711. PubMed ID: 32804418
[TBL] [Abstract][Full Text] [Related]
16. Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders.
Schulz I; Kruse N; Gera RG; Kremer T; Cedarbaum J; Barbour R; Zago W; Schade S; Otte B; Bartl M; Hutten SJ; Trenkwalder C; Mollenhauer B
Mov Disord; 2021 Dec; 36(12):2874-2887. PubMed ID: 34363416
[TBL] [Abstract][Full Text] [Related]
17. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
Kalatha T; Hatzifilippou E; Arnaoutoglou M; Balogiannis S; Koutsouraki E
Hell J Nucl Med; 2019; 22 Suppl 2():113-121. PubMed ID: 31802051
[TBL] [Abstract][Full Text] [Related]
18. Use of Biostatistical Models to Manage Replicate Error in Concussion Biomarker Research.
Tabor JB; Galarneau JM; Penner LC; Cooper J; Ghodsi M; Fraser DD; Wellington CL; Debert CT; Emery CA
JAMA Netw Open; 2023 Oct; 6(10):e2339733. PubMed ID: 37870831
[TBL] [Abstract][Full Text] [Related]
19. Tau and neurofilament light-chain as fluid biomarkers in spinocerebellar ataxia type 3.
Garcia-Moreno H; Prudencio M; Thomas-Black G; Solanky N; Jansen-West KR; Hanna Al-Shaikh R; Heslegrave A; Zetterberg H; Santana MM; Pereira de Almeida L; Vasconcelos-Ferreira A; Januário C; Infante J; Faber J; Klockgether T; Reetz K; Raposo M; Ferreira AF; Lima M; Schöls L; Synofzik M; Hübener-Schmid J; Puschmann A; Gorcenco S; Wszolek ZK; Petrucelli L; Giunti P
Eur J Neurol; 2022 Aug; 29(8):2439-2452. PubMed ID: 35478426
[TBL] [Abstract][Full Text] [Related]
20. A pharmacokinetic and biomarker study of delayed-release dimethyl fumarate in subjects with secondary progressive multiple sclerosis: evaluation of cerebrospinal fluid penetration and the effects on exploratory biomarkers.
Edwards KR; Kamath A; Button J; Kamath V; Mendoza JP; Zhu B; Plavina T; Woodward C; Penner N
Mult Scler Relat Disord; 2021 Jun; 51():102861. PubMed ID: 33773271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
